Aliases & Classifications for Stomatitis

MalaCards integrated aliases for Stomatitis:

Name: Stomatitis 12 74 54 43 15 17 71


External Ids:

Disease Ontology 12 DOID:9637
MeSH 43 D013280
NCIt 49 C26887
SNOMED-CT 67 61170000
ICD10 32 K12.1
UMLS 71 C0038362

Summaries for Stomatitis

MalaCards based summary : Stomatitis is related to hepatitis c virus and lassa fever, and has symptoms including oral mucosal blisters, enanthema and oral manifestations. An important gene associated with Stomatitis is LDLR (Low Density Lipoprotein Receptor), and among its related pathways/superpathways are Innate Immune System and Human cytomegalovirus infection. The drugs Clotrimazole and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include breast, t cells and lung, and related phenotype is immune system.

Wikipedia : 74 Stomatitis is inflammation of the mouth and lips. It refers to any inflammatory process affecting the... more...

Related Diseases for Stomatitis

Diseases related to Stomatitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 537)
# Related Disease Score Top Affiliating Genes
1 hepatitis c virus 30.8 RSAD2 LDLR IFITM3 DDX58 ATG5
2 lassa fever 30.6 IFITM3 DDX58 BST2
3 chikungunya 30.5 TNF RSAD2 DDX58 BST2
4 influenza 30.5 TNF RSAD2 NUP98 IFITM3 IFITM2 DDX58
5 exanthem 30.5 TNF CSF3 CSF2
6 west nile virus 30.4 RSAD2 IFITM3 IFITM2 DDX58
7 dengue virus 30.4 RSAD2 IFITM3 IFITM2 DDX58
8 cyclic neutropenia 30.2 TNF CSF3 CSF2
9 hepatitis c 30.1 TNF RSAD2 LDLR IFNA2 DDX58
10 granulocytopenia 30.1 TNF CSF3 CSF2
11 skin disease 29.8 TP63 TNF FGF7 DDX58 ADAR
12 smallpox 29.8 TNF CSF3 CSF2
13 pyoderma 29.7 TNF IFNA2 CSF3
14 gastroenteritis 29.7 TNF IFNA2 CSF3 CSF2
15 common cold 29.7 TNF LDLR IFNA2 CSF2
16 pyoderma gangrenosum 29.5 TNF IFNA2 CSF3
17 mucositis 29.4 FGF7 DPYD CSF3 CSF2
18 aspergillosis 29.2 TNF CSF3 CSF2
19 neutropenia 29.2 TNF IFNA2 DPYD CSF3 CSF2
20 herpes zoster 29.1 TNF IFNA2 DPYD
21 aphthous stomatitis 12.8
22 denture stomatitis 12.6
23 ulcerative stomatitis 12.6
24 sutton disease 2 12.2
25 noma 11.8
26 hand, foot and mouth disease 11.7
27 riboflavin deficiency 11.5
28 glucagonoma 11.5
29 angular cheilitis 11.5
30 necrotizing ulcerative gingivitis 11.5
31 marshall syndrome 11.4
32 methylmalonic aciduria and homocystinuria, cblf type 11.2
33 pharyngitis 10.8
34 cervical adenitis 10.6
35 vaccinia 10.5
36 mouth disease 10.5
37 herpes simplex 10.5
38 rabies 10.5
39 gingivitis 10.5
40 lichen planus 10.5
41 helix syndrome 10.5
42 vulto-van silfhout-de vries syndrome 10.5
43 candidiasis 10.5
44 viral pneumonia 10.4 TNF IFITM3 DDX58
45 microphthalmia with limb anomalies 10.4 RSAD2 DDX58 BST2 ADAR
46 glossitis 10.4
47 human immunodeficiency virus type 1 10.4
48 pinguecula 10.4 TP63 LDLR IFNA2
49 aicardi-goutieres syndrome 10.4 RSAD2 DDX58 BST2 ADAR
50 oral candidiasis 10.4

Graphical network of the top 20 diseases related to Stomatitis:

Diseases related to Stomatitis

Symptoms & Phenotypes for Stomatitis

UMLS symptoms related to Stomatitis:

oral mucosal blisters, enanthema, oral manifestations, burning mucosal, oral pain, sore roof of mouth (symptom)

MGI Mouse Phenotypes related to Stomatitis:

# Description MGI Source Accession Score Top Affiliating Genes
1 immune system MP:0005387 9.4 ADAR ATG5 CSF2 CSF3 DDX58 FGF7

Drugs & Therapeutics for Stomatitis

Drugs for Stomatitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 361)
# Name Status Phase Clinical Trials Cas Number PubChem Id
Clotrimazole Approved, Vet_approved Phase 4 23593-75-1 2812
Miconazole Approved, Investigational, Vet_approved Phase 4 22916-47-8 4189
Chlorhexidine Approved, Vet_approved Phase 4 55-56-1 9552079 2713
Ethanol Approved Phase 4 64-17-5 702
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
Racepinephrine Approved Phase 4 329-65-7 838
Pemetrexed Approved, Investigational Phase 4 137281-23-3, 150399-23-8 60843 446556
Sodium citrate Approved, Investigational Phase 4 68-04-2
Hexetidine Approved, Investigational Phase 4 141-94-6
Cefpirome Approved Phase 4 84957-29-9 5479539
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
Hydroxocobalamin Approved Phase 4 13422-51-0 15589840 11953898
Silicon Approved, Investigational Phase 4 7440-21-3 4082203
Morphine Approved, Investigational Phase 4 57-27-2 5288826
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
Amifostine Approved, Investigational Phase 4 20537-88-6 2141
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741
Promethazine Approved, Investigational Phase 4 60-87-7 4927
Diphenhydramine Approved, Investigational Phase 4 58-73-1, 147-24-0 3100
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
Magnesium hydroxide Approved, Investigational Phase 4 1309-42-8
Methotrexate Approved Phase 4 59-05-2, 1959-05-2 126941
Simethicone Approved Phase 4 8050-81-5
Povidone Approved Phase 4 9003-39-8
Castor oil Approved, Investigational, Nutraceutical, Vet_approved Phase 4 8001-79-4
Vitamin C Approved, Nutraceutical Phase 4 50-81-7 5785 54670067
Aspartic acid Approved, Nutraceutical Phase 4 56-84-8 5960
Citric acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
Cyanocobalamin Approved, Nutraceutical Phase 4 68-19-9 44176380
Pyridoxine Approved, Investigational, Nutraceutical, Vet_approved Phase 4 65-23-6 1054
Cobalamin Experimental Phase 4 13408-78-1 6857388
32 Antifungal Agents Phase 4
33 Anti-Infective Agents Phase 4
34 Ionophores Phase 4
35 Anti-Infective Agents, Local Phase 4
36 Chlorhexidine gluconate Phase 4
37 Eusol Phase 4
38 Sodium hypochlorite Phase 4
39 Disinfectants Phase 4
40 Castor Phase 4
41 Epinephryl borate Phase 4
42 Folic Acid Antagonists Phase 4
43 N-Methylaspartate Phase 4
Bilirubin Phase 4 69853-43-6, 635-65-4 21252250 5280352
45 Citrate Phase 4
46 Ether Phase 4
47 Norgestimate, ethinyl estradiol drug combination Phase 4
48 Cytochrome P-450 Enzyme Inhibitors Phase 4
49 Vitamin B 12 Phase 4
50 Vitamin B12 Phase 4

Interventional clinical trials:

(show top 50) (show all 320)
# Name Status NCT ID Phase Drugs
1 Effectiveness of Low Energy Laser Treatment in Oral Mucositis Induced by Chemotherapy and Radiotherapy in Head and Neck Cancer Unknown status NCT01876407 Phase 4
2 A Randomized Study on the Effects of Lactobacillus Brevis CD2 in the Prevention of Radio and Chemotherapy Induced Oral Mucositis in Head and Neck Cancer Patients. Unknown status NCT01707641 Phase 4
3 Efficacy of Two Different Oral Hygiene Regimens on the Incidence and Severity of Oral Mucositis in Patients Receiving Hematopoietic Stem Cell Transplantation - A Randomized Controlled Trial Unknown status NCT02662374 Phase 4 .02% Chlorohexidine Gluconate;3% Sodium Bicarbonate;Nystatin 10000U/ml;Supersaturated Calcium Phosphate
4 Local Administration of Morphine: An Evaluation of the Analgesic Effect at Stomatitis in Children Completed NCT00357942 Phase 4 morphine solution for injection;Placebo;morphine mouthwash;Placebo
5 Photodynamic Therapy Against Candida Spp. in Complete Denture Wearers: a Randomized Clinical Trial Completed NCT02642900 Phase 4 Nystatin 100.000 units
6 A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck Completed NCT01283906 Phase 4
7 Clinical Evaluation of an Experimental Solution Based on Ricinus Communis Compared to Sodium Hypochlorite for Denture Cleansing Completed NCT02407834 Phase 4
8 Open-Label Single-Arm Phase IV Study of Pemetrexed in Taiwanese Patients With Advanced Non-Small Cell Lung Cancer Who Have Had Prior Chemotherapy Completed NCT00380718 Phase 4 pemetrexed
9 Evaluation of the Efficacy of a Hexetidine- and Chlorobutanol-based Mouthwash in the Symptomatic Treatment of Oral Lesions Due to Removable Prostheses: a Prospective, Randomized, Triple-blind Controlled Clinical Trial Completed NCT01115049 Phase 4 chlorobutanol, hexetidine;Chlorhexidine
10 Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration Completed NCT00280514 Phase 4 cefpirome and moxifloxacin administration
11 Clinical Study of the Effects of Compound Kushen Injection on Radiation-induced Oral Mucositis in Head and Neck Cancer Patients. Recruiting NCT04204382 Phase 4 Levofloxacin injection;Compound kushen injection
12 Celiac Disease and Vitamin Status: Evaluation of the Effect of Supplementation With a Probiotic (VIVOMIXX®) on Vitamin B6, B12, 25'OH D, Folic Acid and Omocystein Levels, Metabolic and Inflammatory Status, and Gut Microbiota Metabolomics in a Cohoort of Celiac Patients Recruiting NCT04160767 Phase 4 Probiotic Vivomixx
13 A Comparison of Oral Controlled-release Morphine With Transdermal Fentanyl in Nasopharyngeal Cancer Patients With Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy Not yet recruiting NCT04292990 Phase 4 Fentanyl;Morphine
14 Prospective, Open-label, Randomized, Control Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine Suspended NCT01288625 Phase 4 Amifostine
15 An Adaptive Design, Single-Blind, Randomized, Controlled Study Investigating Polyvinylpyrrolidone (PVP) and Sodium Hyaluronate-Containing Oral Gel (Gelclair®) in Comparison to Viscous Lidocaine, Diphenhydramine, and Aluminum-magnesium Hydroxide/Simethicone Antacid Suspension Mouthwash ("Magic Mouthwash") for the Management of Oral Mucositis Associated With High Dose Chemotherapy and Methotrexate in Allogeneic Stem Cell Transplant Recipients Terminated NCT03490396 Phase 4
16 Ketorolac for Analgesia followiNG Autologous Breast RecOnstructiOn Withdrawn NCT03007381 Phase 4 Ketorolac Tromethamine;Normal Saline
17 The Clinical Study for Evaluation of Efficacy and Safety of EGF on Oral Mucositis in Radiation Therapy Patients Unknown status NCT01099891 Phase 3 rhEGF;Placebo
18 A Pilot Study on the Efficacy of Lactobacillus Brevis CD2 Lozenges in Preventing Oral Mucositis by High-dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation Unknown status NCT02085694 Phase 2, Phase 3 Lactobacillus brevis CD2
19 The Efficacy of Topical Minocycline in Managing Symptomatic Oral Lichen Planus. A Randomized Controlled Trial Unknown status NCT01083420 Phase 3 Minocycline;Dexamethasone
20 A Randomized, Double-Blind, Placebo-Controlled Pilot Study for Evaluating the Efficacy of the Homeopathic Remedy Traumeel S on Pain Reduction Following Tonsillectomy in Adult Patients. Unknown status NCT00410332 Phase 3 Traumeel S;Placebo
21 A Multinational, Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase III Clinical Trial to Determine the Efficacy and Safety of IB-367 Rinse in Reducing the Severity of Oral Mucositis in Patients Receiving Radiotherapy for Head and Neck Malignancy Unknown status NCT00022373 Phase 3 iseganan HCl oral solution
22 Laser Therapy Prevents Mucositis Oral in Patients Undergoing to Chemotherapy for Bone Marrow Transplantation? A Randomized Clinical Trial. Unknown status NCT02020928 Phase 3
23 Evaluation of Low-energy Laser Therapy for Prevention and Reduction of Severity of Oral Mucositis in Children "Mucositis Laser 1" Unknown status NCT01007617 Phase 2, Phase 3
24 Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic in Elderly People Completed NCT02818803 Phase 3 Miconazole
25 Prevention of Recurrent Aphthous Stomatitis Using Vitamins Completed NCT00527306 Phase 3
26 Effectiveness of Topical Hyaluronic Acid Versus Chlorhexidine Mouthwashes in the Treatment of Recurrent Aphthous Stomatitis: A Randomized Clinical Trial Completed NCT04265001 Phase 3 Hyaluronic acid in the form of hyaluronan sodium 25 mg/100 ml as a mouthwash
27 Effect of Low-level Laser Therapy on Inflammatory Mediators Release During Chemotherapy-induced Oral Mucositis: a Randomized Preliminary Study Completed NCT02050373 Phase 3
28 A Randomized,Controlled Clinical Trial on the Efficacy and Safety of Chining Decoction in the Treatment of Radiation Stomatitis. Completed NCT02303197 Phase 3 ChiNing decoction
29 Evaluating the Effectiveness of Topical Morphine Compared With a Routine Mouthwash in Managing Cancer Treatment-induced Mucositis in Patients With Head and Neck Cancer in Isfahan Completed NCT01837446 Phase 2, Phase 3 2% morphine solution;Magnesium aluminum hydroxide;2% viscous lidocaine;Diphenhydramine
30 LAMPO: Multicenter Randomized Double-blind Controlled Trial to Evaluate the Efficacy of Laser Therapy for Treatment of Oral Mucositis Induced by Chemotherapy in Children Completed NCT02762019 Phase 3
31 A Double-Blind, Randomized, Vehicle-Controlled Study Comparing the Safety and Efficacy of Benzydamine HCl 0.15% Oral Rinse Including a Separate Open-Label Standard of Care Arm in Subjects With Radiation-Induced Mucositis Completed NCT00051441 Phase 3 Benzydamine Hydrochloride 0.15% Oral Rinse
32 A Phase 3, Randomized, Double-blind, Placebo-controlled Trial of Recombinant Human Keratinocyte Growth Factor for Reduction of Mucositis in Patients With Hematologic Malignancies Undergoing Total Body Irradiation and High-dose Chemotherapy With Autologous PBPC Transplantation Completed NCT00041665 Phase 3 Recombinant Human Keratinocyte Growth Factor
33 A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2 Completed NCT00001812 Phase 3 Nystatin
34 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Study to Assess the Efficacy and Safety of SBG on Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiation Therapy With or Without Chemotherapy Completed NCT00790322 Phase 3 SBG
35 A Randomized, Blinded, Active-control Trial of Palifermin (rHuKGF) to Evaluate Oral Mucositis in Subjects With Hematologic Malignancies Undergoing Fractionated Total Body Irradiation (fTBI) and High Dose Chemotherapy With Autologous Peripheral Blood Progenitor Cell (PBPC) Transplantation Completed NCT00109031 Phase 3 palifermin;Cyclophosphamide;Etoposide;Placebo
36 Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Weekly Doses of Palifermin (rHuKGF) for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer Receiving Radiotherapy With Concurrent Chemotherapy (RT/CT) Completed NCT00101582 Phase 3 Placebo;palifermin;cisplatin chemotherapy
37 A Phase II/III Blinded Randomized Trial to Determine the Efficacy of Low Energy Diode Laser Therapy (650 nm or 780 nm) to Prevent Oral Mucositis Following Bone Marrow Transplantation Completed NCT00024037 Phase 2, Phase 3
38 [rVSVΔG-ZEBOV] Ebola Prevention Vaccine Evaluation in Sierra Leone Completed NCT02378753 Phase 2, Phase 3
39 Evaluation of Oral Care to Prevent Oral Mucositis in Estrogen Receptor Positive Metastatic Breast Cancer Patients Treated With Everolimus: Phase III Randomized Control Trial Completed NCT02376985 Phase 3 Everolimus
40 A Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Palifermin (Recombinant Human Keratinocyte Growth Factor) for Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer Receiving 5-FU and Leucovorin as Adjuvant Therapy Completed NCT00393822 Phase 2, Phase 3 palifermin;placebo
41 Evaluate Safety and Tolerability and Compare Absorption/Distribution Kinetics of a Single 100 Mcg Dose of Fentanyl Sublingual Spray (Fentanyl SL Spray) in Cancer Subjects With or Without Oral Mucositis Completed NCT00956254 Phase 3 Fentanyl sublingual spray
42 Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Weekly Doses of Palifermin (rHuKGF) for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer Receiving Adjuvant Radiotherapy and Chemotherapy(RT/CT) Completed NCT00131638 Phase 3 Placebo;Palifermin
43 Clinical Phase III Trial to Compare Treosulfan-based Conditioning Therapy With Busulfan-based Reduced-intensity Conditioning (RIC) Prior to Allogeneic Haematopoietic Stem Cell Transplantation in Patients With AML or MDS Considered Ineligible to Standard Conditioning Regimens Completed NCT00822393 Phase 3 Busulfan;Treosulfan
44 A Double-Blind, Randomized, Placebo-controlled Study of Two Different Schedules of Palifermin for Reduction in Severity of Oral Mucositis in Subjects With Multiple Myeloma Receiving Melphalan Followed by Autologous Blood Stem Cell Transplantation Completed NCT00434161 Phase 3 Palifermin before only;Placebo;Palifermin before and after
45 Khon Kaen University Ethics Committee in Human Research Completed NCT02536781 Phase 2, Phase 3 Anthocyanin;Placebo
46 A Randomized Placebo-Controlled Trial of Manuka Honey for Oral Mucositis Due to Radiation Therapy for Cancer Completed NCT00615420 Phase 3
47 Efficacy of Prophylactic Low Level Laser Therapy (LLLT) Performed by Nurses for Decreasing Severity of Oral Mucositis During Hematopoietic Stem Cell (HSC) Transplantation : a Randomized Double Blind Multicenter Prospective Phase III Trial Completed NCT02696408 Phase 3
48 Phase III Trial of Low-level Laser Therapy to Prevent Induced Oral Mucositis in Head and Neck Cancer Patients Submitted to Concurrent Chemoradiation Completed NCT01439724 Phase 3
49 Phase III Randomized Double-blind Cross-over Trial of Caphosol® Versus NaCl 0.9% in the Relief of Oral Mucositis in Renal Cell Carcinoma, Hepatocellular Carcinoma, and Gastrointestinal Stromal Tumor Patients Receiving Targeted Therapy Completed NCT01265810 Phase 3
50 Effect of Ascorbic Acid Oral Supplementation in Assessing the Severity of Oral Mucositis in Chemo-radiation Therapy of Head and Neck Cancers. Completed NCT02868151 Phase 2, Phase 3 Ascorbic Acid;Zinc acetate

Search NIH Clinical Center for Stomatitis

Inferred drug relations via UMLS 71 / NDF-RT 50 :

carbamide peroxide

Cochrane evidence based reviews: stomatitis

Genetic Tests for Stomatitis

Anatomical Context for Stomatitis

MalaCards organs/tissues related to Stomatitis:

Breast, T Cells, Lung, Bone, Testes, Bone Marrow, Skin

Publications for Stomatitis

Articles related to Stomatitis:

(show top 50) (show all 14471)
# Title Authors PMID Year
A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer. 61 54
17520255 2008
DPYD*2A mutation: the most common mutation associated with DPD deficiency. 54 61
17165084 2007
Phase II trial of pralatrexate (10-propargyl-10-deazaaminopterin, PDX) in patients with unresectable malignant pleural mesothelioma. 54 61
17409804 2007
First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study with a simplified biweekly schedule. 54 61
15550581 2004
Thymidylate synthase expression in normal colonic mucosa: a predictive marker of toxicity in colorectal cancer patients receiving 5-fluorouracil-based adjuvant chemotherapy. 54 61
15539918 2004
Relationship between plasma concentrations of 5-fluorouracil and 5-fluoro-5,6-dihydrouracil and toxicity of 5-fluorouracil infusions in cancer patients. 61 54
12352929 2002
Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil. 54 61
10473079 1999
Dihydropyrimidine dehydrogenase deficiency: a pharmacogenetic defect causing severe adverse reactions to 5-fluorouracil-based chemotherapy. 54 61
9007910 1997
High dose busulphan/cyclophosphamide for autologous bone marrow transplantation is associated with minimal non-hemopoietic toxicity. 61 54
7524888 1994
Production of bioactive human IFN-γ protein by agroinfiltration in tobacco. 61
32179088 2020
Safety and efficacy of sirolimus combined with endocrine therapy in patients with advanced hormone receptor-positive breast cancer and the exploration of biomarkers. 61
32335491 2020
Ulvan lyase assisted structural characterization of ulvan from Ulva pertusa and its antiviral activity against vesicular stomatitis virus. 61
32344076 2020
Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 study. 61
32449149 2020
Blood Outgrowth Endothelial Cells as a Cellular Carrier for Oncolytic Vesicular Stomatitis Virus Expressing Interferon-β in Preclinical Models of Non-Small Cell Lung Cancer. 61
32422574 2020
Oral changes associated with kolanut use: a report of 2 cases. 61
32418737 2020
SUMOylation of DDX39A Alters Binding and Export of Antiviral Transcripts to Control Innate Immunity. 61
32393512 2020
TRIM24 facilitates antiviral immunity through mediating K63-linked TRAF3 ubiquitination. 61
32324863 2020
Allergic contact stomatitis caused by propolis throat candies. 61
32185806 2020
Oncolytic vesicular stomatitis viruses selectively target M2 macrophages. 61
32360866 2020
Vitamin D and hematinic deficiencies in patients with recurrent aphthous stomatitis. 61
31680206 2020
Depression symptoms and recurrent aphthous stomatitis-Evidence from a population-based study in Indonesia. 61
32031742 2020
Management Strategies for Reducing the Risk of Equines Contracting Vesicular Stomatitis Virus (VSV) in the Western United States. 61
32534788 2020
Celiac disease and hematological abnormalities in children with recurrent aphthous stomatitis. 61
31957941 2020
Common genetic susceptibility loci link PFAPA syndrome, Behçet's disease, and recurrent aphthous stomatitis. 61
32518111 2020
Serostatus cutoff levels and fold increase to define seroresponse to recombinant vesicular stomatitis virus - Zaire Ebola virus envelope glycoprotein vaccine: An evidence-based analysis. 61
32499064 2020
Vesicular stomatitis virus glycoprotein suppresses nuclear factor kappa-B- and mitogen-activated protein kinase-mediated pro-inflammatory responses dependent on sialic acids. 61
32126199 2020
IgA Summons IgG to Take a Hit at HIV-1. 61
32526180 2020
Discovery of Adamantane Carboxamides as Ebola Virus Cell Entry and Glycoprotein Inhibitors. 61
32550996 2020
Monitoring Neutralization Property Change of Evolving Hantaan and Seoul Viruses with a Novel Pseudovirus-Based Assay. 61
32533414 2020
Rosuvastatin Enhances VSV-G Lentiviral Transduction of NK Cells via Upregulation of the Low-Density Lipoprotein Receptor. 61
32300610 2020
Berunda polypeptides carrying rapalogues inhibit tumor mTORC1 better than oral everolimus. 61
32484665 2020
T cell engagement of cross-presenting microglia protects the brain from a nasal virus infection. 61
32503876 2020
VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA. 61
32315598 2020
Impact of modified short-term fasting and its combination with a fasting supportive diet during chemotherapy on the incidence and severity of chemotherapy-induced toxicities in cancer patients - a controlled cross-over pilot study. 61
32571329 2020
Modified Alphavirus-Vesiculovirus Hybrid Vaccine Vectors for Homologous Prime-Boost Immunotherapy of Chronic Hepatitis B. 61
32517032 2020
Why and How Should We Treat Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome? 61
32342289 2020
Examination of vesicular stomatitis virus-induced morphology changes in individual Vero cells by QMod microscopy. 61
32202142 2020
A family-based genome-wide association study of recurrent aphthous stomatitis. 61
32558109 2020
MAP3K7 and CHD1 Are Novel Mediators of Resistance to Oncolytic Vesicular Stomatitis Virus in Prostate Cancer Cells. 61
32529027 2020
Glutamine for Amelioration of Radiation and Chemotherapy Associated Mucositis during Cancer Therapy. 61
32512833 2020
Analysis of DNA methylation and TP53 mutational status for differentiating feline oral squamous cell carcinoma from non-neoplastic mucosa: a preliminary study. 61
32506786 2020
Vesicular stomatitis virus and DNA vaccines expressing Zika virus nonstructural protein 1 (NS1) induce substantial but not sterilizing protection against Zika virus infection. 61
32554698 2020
Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor. 61
32321812 2020
Preparation and qualification of internal rabies reference standards for use in the rabies rapid fluorescent focus inhibition test. 61
32555434 2020
Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutations. 61
32497289 2020
Guanidine derivative inhibits C. albicans biofilm growth on denture liner without promote loss of materials' resistance. 61
32123776 2020
Suppressive effects of 2-methacryloyloxyethyl phosphorylcholine (MPC)-polymer on the adherence of Candida species and MRSA to acrylic denture resin. 61
32577575 2020
In vitro evaluation of physicochemical properties of soft lining resins after incorporation of chlorhexidine. 61
32540125 2020
Impact of caffeine on metabolic activity and biofilm formation of Candida albicans on acrylic denture resin in the presence of nicotine. 61
31703923 2020
Comparison of Platinum/S-1 and Platinum/5-Fluorouracil as First-Line Chemotherapy for Advanced Gastric or Gastroesophageal Junction Cancer: A Meta-Analysis Based on Randomized Controlled Trials. 61
32535588 2020

Variations for Stomatitis

Expression for Stomatitis

Search GEO for disease gene expression data for Stomatitis.

Pathways for Stomatitis

Pathways related to Stomatitis according to GeneCards Suite gene sharing:

(show all 18)
# Super pathways Score Top Affiliating Genes
Show member pathways
Show member pathways
Show member pathways
Show member pathways
Show member pathways
12.38 UBA52 IFNA2 DDX58 ADAR
Show member pathways
7 12.21 UBA52 TNF CSF2 ATG5 ATG12
8 12.1 TNF IFNA2 ATG5 ATG12
Show member pathways
Show member pathways
11 11.86 TNF IFNA2 CSF3 CSF2
12 11.73 TNF CSF3 CSF2
13 11.59 TNF IFNA2 CSF2
14 11.47 TNF FGF7 CSF3 CSF2
15 11.39 TNF CSF3 CSF2
Show member pathways
11.35 UBA52 ATG5 ATG12
17 11.1 TNF CSF3 CSF2
Show member pathways
10.94 IFNA2 DDX58 ADAR

GO Terms for Stomatitis

Cellular components related to Stomatitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 phagophore assembly site membrane GO:0034045 8.96 ATG5 ATG12
2 Atg12-Atg5-Atg16 complex GO:0034274 8.62 ATG5 ATG12

Biological processes related to Stomatitis according to GeneCards Suite gene sharing:

(show all 18)
# Name GO ID Score Top Affiliating Genes
1 immune system process GO:0002376 10.02 RSAD2 IFITM3 IFITM2 DDX58 BST2 ATG5
2 innate immune response GO:0045087 10 RSAD2 IFITM3 IFITM2 DDX58 BST2 ADAR
3 immune response GO:0006955 9.96 TNF IFITM3 IFITM2 CSF3 CSF2
4 viral process GO:0016032 9.95 RSAD2 NUP98 LDLR DDX58 ATG5 ATG12
5 cytokine-mediated signaling pathway GO:0019221 9.89 UBA52 TNF IFNA2 CSF3 CSF2
6 defense response to virus GO:0051607 9.8 RSAD2 IFNA2 IFITM3 IFITM2 DDX58 BST2
7 negative regulation of viral genome replication GO:0045071 9.72 TNF RSAD2 IFITM3 IFITM2 BST2
8 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.71 TNF IFNA2 CSF2
9 response to interferon-gamma GO:0034341 9.63 IFITM3 IFITM2 BST2
10 negative regulation of viral entry into host cell GO:0046597 9.61 IFNA2 IFITM3 IFITM2
11 positive regulation of keratinocyte proliferation GO:0010838 9.58 TP63 FGF7
12 positive regulation of podosome assembly GO:0071803 9.57 TNF CSF2
13 autophagy of nucleus GO:0044804 9.55 ATG5 ATG12
14 response to interferon-beta GO:0035456 9.54 IFITM3 IFITM2 BST2
15 C-terminal protein lipidation GO:0006501 9.51 ATG5 ATG12
16 response to interferon-alpha GO:0035455 9.46 IFITM3 IFITM2 BST2 ADAR
17 type I interferon signaling pathway GO:0060337 9.43 RSAD2 IFNA2 IFITM3 IFITM2 BST2 ADAR
18 response to virus GO:0009615 9.17 TNF RSAD2 IFITM3 IFITM2 DDX58 BST2

Molecular functions related to Stomatitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 8.92 TNF IFNA2 CSF3 CSF2

Sources for Stomatitis

9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
31 HPO
32 ICD10
33 ICD10 via Orphanet
37 LifeMap
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
54 Novoseek
57 OMIM via Orphanet
61 PubMed
70 Tocris
72 UMLS via Orphanet
Loading form....